Comer: FDA Must Provide Americans Guidance on CBD Products
April 19, 2023
April 19, 2023
WASHINGTON, April 19 -- Rep. James Comer, R-Kentucky, issued the following news release and letter:
Congressman James Comer (R-Ky.) is investigating the Food and Drug Administration's (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Congressman Comer raises concern that the agency's failure to regulate CBD products could allow dangerous products to come to marke . . .
Congressman James Comer (R-Ky.) is investigating the Food and Drug Administration's (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Congressman Comer raises concern that the agency's failure to regulate CBD products could allow dangerous products to come to marke . . .